Pharmacovigilence for Retapamulin: Age-stratified Monitoring of Prescribed Use in the European Union.
Phase of Trial: Phase IV
Latest Information Update: 07 Jun 2013
At a glance
- Drugs Retapamulin (Primary) ; Fusidic acid; Mupirocin
- Indications Bacterial infections; Impetigo
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 13 Apr 2012 Planned number of patients 1 added as reported by ClinicalTrials.gov.
- 07 Jul 2010 New trial record